AI, Empowerment, and the Future of Health Product Innovation
Two major factors are currently driving product innovation: the rise of AI and the increasing need for patient empowerment in the face of healthcare challenges, such as limited doctor visit times.
Responsible AI: Innovation Within a Vetted Environment
Munnelly highlights AI as a major trend. However, in healthcare, the biggest differentiator for Health Union is its commitment to responsible AI usage.
“I think we will see an increasing emphasis on using AI within within contained environments for health,” Munnelly explains. Health Union’s AI-powered products operate within its own closed environment, using only vetted Health Union content, which offers a safety and reliability advantage over big AI platforms that can pull from anywhere on the web.
A few of Health Union’s key products include My Journ.ai, which leverages machine learning to process users’ self-check results and render articles relevant to their experience. Another, Hear + Now, utilizes AI to create audio content, providing critical accessibility for users.
Empowering the Confident Patient
Acknowledging that patients only get a few minutes of face time with a provider, Health Union also develops products designed to help patients be self-advocates.
“The Confident Patient” Doctor Discussion Guide helps walk patients through preparing for HCP conversations, so they can walk in “armed with questions” and clear goals. Munnelly stresses that this toolkit is vital because “it’s really stressful to be a patient,” and it’s easy to forget key questions in the moment.
These patient-empowering products also deliver significant value to our brand partners by ensuring their messaging is placed within a trusted, high-engagement environment. By reaching patients who are actively seeking relevant information and preparing for treatment discussions, these tools position our brand partners as essential parts of the patient’s informed decision-making process. This targeted approach guarantees brands reach the right people at the right moments in their health journey, leading to more productive conversations with their healthcare providers.
Looking Ahead: The Role of Patient Leaders and Rare Disease
Looking to the future, Munnelly points to the growing rare disease space as a critical area that will shape product innovation. With increasing new drug approvals, the need for flexible products that serve these small, unique populations—who have different needs and difficulties finding information and specialized physicians—will become paramount.
She emphasizes the immense value of Health Union’s Social Health Network of patient leaders. These leaders are “hyper specific” and driven by a selfless passion to share their authentic, often vulnerable, day-to-day lives, from managing medications to changing medical devices.
“That big network really sets us apart in being able to develop products that will involve our patient leaders… in ways that are really valuable for both our clients as well as our community members,” Munnelly says.
Ultimately, every product strategy at Health Union returns to its core philosophy: community first. Pam adds, “Our patient communities are our heartbeat. They inform and shape everything we do, and they’re instrumental to the success of our clients.”








